Maternal preeclampsia predicts the development of bronchopulmonary dysplasia

Anne R Hansen1, Carmen M Barnés, Judah Folkman

  • 1Division of Newborn Medicine, Children's Hospital, Boston, MA 02115, USA. anne.hansen@childrens.harvard.edu

The Journal of Pediatrics
|December 17, 2009
PubMed

Insights

Infants exposed to preeclampsia face a significantly higher risk of developing bronchopulmonary dysplasia (BPD). This finding suggests potential new avenues for BPD prevention strategies in high-risk newborns.

Area of Science:

  • Neonatal Medicine
  • Perinatal Research
  • Pulmonary Medicine

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants.
  • Preeclampsia is a serious pregnancy complication characterized by high blood pressure.
  • The relationship between maternal preeclampsia and neonatal respiratory outcomes requires further investigation.

Purpose of the Study:

  • To investigate the association between prenatal exposure to preeclampsia and the risk of developing bronchopulmonary dysplasia (BPD) in preterm infants.
  • To quantify the risk of BPD in infants born to mothers with preeclampsia.

Main Methods:

  • Prospective cohort study involving 107 infants born between 23 and 32 weeks of gestation.
  • Collection of comprehensive maternal, neonatal, and placental data.
  • Statistical analysis including bivariate and multivariable logistic regression to assess the odds ratio (OR) for BPD.

Main Results:

  • 25% of the studied infants developed BPD.
  • Maternal preeclampsia was significantly associated with an increased risk of BPD (bivariate OR = 2.96).
  • After adjusting for confounders, the association remained strong, with an adjusted OR of 18.7 for developing BPD in infants exposed to preeclampsia.

Conclusions:

  • Infants exposed to preeclampsia exhibit an increased risk of developing bronchopulmonary dysplasia.
  • These findings suggest that preeclampsia may be a significant risk factor for BPD.
  • Targeting proangiogenic pathways, potentially with agents like vascular endothelial growth factor, could be a future strategy for BPD prevention in this population.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...